Hedgehog Inhibitors in the Age of Immunotherapy
In the age of immunotherapy, is there a place for hedgehog inhibitors in cutaneous oncology?
ODAC Guest Advisor Dr. Vishal Patel says hedgehog inhibitors are even more important now. Dr. Patel spoke with Next Steps in Derm, in partnership with the ODAC Dermatology Conference, where he outlined scenarios in clinical treatment where hedgehog inhibitors make sense. Learn about the two approved m …
In the age of immunotherapy, is there a place for hedgehog inhibitors in cutaneous oncology?
ODAC Guest Advisor Dr. Vishal Patel says hedgehog inhibitors are even more important now. Dr. Patel spoke with Next Steps in Derm, in partnership with the ODAC Dermatology Conference, where he outlined scenarios in clinical treatment where hedgehog inhibitors make sense. Learn about the two approved m … Continue reading "Hedgehog Inhibitors in the Age of Immunotherapy"
Dermatologists play a crucial role in the care of patients with sexually transmitted diseases (STDs), as many STDs manifest on the skin. At the 2024 Skin of Color Update, Dr. Theodore Rosen, Professor of Dermatology at Baylor College of Medicine, shared valuable insights on diagnosing and managing STDs in patients with skin of color. This article reviews the prevalence of STDs, their distinctive p … 
At the 2025 ODAC Dermatology Conference, we had the privilege of hearing from Dr. Adam Friedman, a renowned expert in dermatology and the chair of the department of dermatology at the George Washington, as he shared his expert insights into the evolving landscape of off-label treatments for challenging dermatologic conditions. Dr. Friedman addressed the complexities of managing conditions such as … 
At the 2025 ODAC Dermatology Conference, Dr. Amy McMichael, distinguished professor of dermatology at Wake Forest University School of Medicine, shared her expertise on “Management Strategies for Nonscarring Alopecias.” She focused on pattern hair loss and alopecia areata, weaving in evidence and practical pearls.
Pattern Hair Loss
Dr. McMichael discussed important management considerations … 
Ketoconazole is an imidazole antifungal that was initially FDA-approved in an oral formulation for the treatment of systemic fungal infections. While oral ketoconazole has largely fallen out of use due to safety concerns, including hepatotoxicity, endocrine dysregulation, and drug interactions, topical ketoconazole has proven to be a safe and effective treatment for superficial fungal infections. …